Marksans Pharma Share Price Target 2030 | (2026-2027 to 2050)
Marksans Pharma Share Price Target 2026 2027 2028 2029 2030 2035 2040 2045 2050 accurate price prediction with target calculator, just enter ur expected cagr and it will show you target
Marksans Pharma Share Price Statistic
The Marksans Pharma Share Price Statistics section summarizes the stock's key historical performance metrics, including the current share price, daily, weekly, monthly, yearly, and long-term returns. It also highlights the best and worst calendar years, average annual return, maximum drawdown, and the number of positive years. These statistics provide a quick snapshot of Marksans Pharma's historical performance and help investors understand its long-term return profile and market volatility.
CURRENT PRICE
1 DAY
1 WEEK
1 MONTH
6 MONTHS
1 YEAR
3 YEARS
5 YEARS
BEST YEAR
WORST YEAR
AVERAGE YEAR
POSITIVE YEARS
Marksans Pharma Target and CAGR Calculator
The Marksans Pharma Target Calculator helps you to calculate future share price Marksans Pharma CAGR Calculator calculates historical annualized returns over different investment periods. Together, these tools help investors compare past performance with future expectations.So you can be realistic about future price.
Marksans Pharma Target Price Calculator
The Marksans Pharma Target Price Calculator estimates the future share price based on your expected annual return (CAGR) and investment period. Simply choose a target year and expected growth rate to calculate the projected share price, expected return, and total gain. Just enter your Target Year and Expected Returns, and get target instantly.
Target Price
₹0.00
0 years
0%
₹0
Marksans Pharma CAGR Calculator
Use the Marksans Pharma CAGR Calculator to calculate the compound annual growth rate (CAGR) for any investment period. You can check historical CAGR for the last 1, 2, 3, 5, 10, 15, 20, 25, and 30 years, or select any available period to understand the company's long-term performance. This helps investors compare returns across different investment horizons and evaluate long-term wealth creation.
Just Select no of years you want to check cagr
Marksans Pharma Charts
The Marksans Pharma Charts provides interactive historical charts, including the price chart, drawdown chart, yearly return chart, and monthly return chart. Analyze long-term trends, compare performance across different periods, identify major corrections, and understand the stock's historical volatility using multiple time ranges from 1 month to the maximum available data.
Marksans Pharma Historical Returns & Price History
Check out Marksans Pharma's historical returns and daily price history in one place. The historical returns table shows monthly and yearly percentage returns, It will make you easy to identify strong and weak periods, seasonal trends, and long-term performance. You can check which month Marksans Pharma stock is performing well and which it is not. The historical price data table provides daily Open, High, Low, and Close (OHLC) prices, allowing investors to analyze past price movements and compare historical trading activity.
Marksans Pharma Performance
The Marksans Pharma Historical Returns table displays monthly and yearly returns for each calendar year. It helps you to understand how the stock has performed across different market cycles.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yearly |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loading... | |||||||||||||
Marksans Pharma Price History
The Marksans Pharma Historical Price Data table provides daily Open, High, Low, and Close (OHLC) prices. Use the year and month filters to view historical trading data
| Date | Open (₹) | High (₹) | Low (₹) | Close (₹) |
|---|---|---|---|---|
| Loading data... | ||||
Marksans Pharma Share Price Target Tomorrow
| Targets | Stoploss | |
|---|---|---|
| 1 | ₹309.53 | ₹302.33 |
| 2 | ₹312.97 | ₹298.57 |
| 3 | ₹316.73 | ₹295.13 |
Marksans Pharma Share Price Target Tomorrow is ₹309.53, 2nd target is ₹312.97, and 3rd target is ₹316.73. For risk management, the 1st stoploss is at ₹302.33 and 2nd (wider) stoploss is at ₹298.57.
Marksans Pharma Share Price Target Next Week
| Targets | Stoploss | |
|---|---|---|
| 1 | ₹316.00 | ₹299.10 |
| 2 | ₹325.90 | ₹292.10 |
| 3 | ₹332.90 | ₹282.20 |
Marksans Pharma Share Price Target Next Week is ₹316.00, 2nd target is ₹325.90, and 3rd target is ₹332.90. For risk management, the 1st stoploss is at ₹299.10 and 2nd (wider) stoploss is at ₹292.10.
Marksans Pharma Share Price Target Next Month
| Targets | Stoploss | |
|---|---|---|
| 1 | ₹337.87 | ₹278.62 |
| 2 | ₹369.53 | ₹251.03 |
| 3 | ₹397.12 | ₹219.37 |
Marksans Pharma Share Price Target Next Month is ₹337.87, 2nd target is ₹369.53, and 3rd target is ₹397.12. For risk management, the 1st stoploss is at ₹278.62 and 2nd (wider) stoploss is at ₹251.03.
MARKSANS PHARMA Share Price Target 2026
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 8% | ₹330.70 | ₹269.46 |
| 2 | 17% | ₹358.25 | ₹263.33 |
| 3 | 28% | ₹391.94 | ₹235.77 |
* Targets calculated based on the latest available price as of 2026-10-30.
Marksans Pharma Share Price Target 2026 is ₹330.70 (8% CAGR), 2nd target is ₹358.25 (17% CAGR), and 3rd target is ₹391.94 (28% CAGR). For risk management, the 1st stoploss is at ₹269.46 and 2nd (wider) stoploss is at ₹263.33.
MARKSANS PHARMA Share Price Target 2027
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 9% | ₹333.65 | ₹310.29 |
| 2 | 17% | ₹358.14 | ₹283.60 |
| 3 | 27% | ₹388.75 | - |
* Targets are projected using historical CAGR and market assumptions.
Marksans Pharma Share Price Target 2027 is ₹333.65 (9% CAGR), 2nd target is ₹358.14 (17% CAGR), and 3rd target is ₹388.75 (27% CAGR). For risk management, the 1st stoploss is at ₹310.29 and 2nd (wider) stoploss is at ₹283.60.
MARKSANS PHARMA Share Price Target 2028
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 9% | ₹363.68 | ₹338.22 |
| 2 | 17% | ₹419.02 | ₹309.13 |
| 3 | 27% | ₹493.71 | - |
* Targets are projected using historical CAGR and market assumptions.
Marksans Pharma Share Price Target 2028 is ₹363.68 (9% CAGR), 2nd target is ₹419.02 (17% CAGR), and 3rd target is ₹493.71 (27% CAGR). For risk management, the 1st stoploss is at ₹338.22 and 2nd (wider) stoploss is at ₹309.13.
MARKSANS PHARMA Share Price Target 2029
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 9% | ₹396.41 | ₹368.66 |
| 2 | 17% | ₹490.25 | ₹336.95 |
| 3 | 27% | ₹627.01 | - |
* Targets are projected using historical CAGR and market assumptions.
Marksans Pharma Share Price Target 2029 is ₹396.41 (9% CAGR), 2nd target is ₹490.25 (17% CAGR), and 3rd target is ₹627.01 (27% CAGR). For risk management, the 1st stoploss is at ₹368.66 and 2nd (wider) stoploss is at ₹336.95.
MARKSANS PHARMA Share Price Target 2030
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 9% | ₹432.09 | ₹401.84 |
| 2 | 17% | ₹573.60 | ₹367.27 |
| 3 | 27% | ₹796.30 | - |
* Targets are projected using historical CAGR and market assumptions.
Marksans Pharma Share Price Target 2030 is ₹432.09 (9% CAGR), 2nd target is ₹573.60 (17% CAGR), and 3rd target is ₹796.30 (27% CAGR). For risk management, the 1st stoploss is at ₹401.84 and 2nd (wider) stoploss is at ₹367.27.
MARKSANS PHARMA Share Price Target 2035
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 9% | ₹664.82 | ₹618.28 |
| 2 | 17% | ₹1,257.58 | ₹565.09 |
| 3 | 27% | ₹2,630.85 | - |
* Targets are projected using historical CAGR and market assumptions.
Marksans Pharma Share Price Target 2035 is ₹664.82 (9% CAGR), 2nd target is ₹1,257.58 (17% CAGR), and 3rd target is ₹2,630.85 (27% CAGR). For risk management, the 1st stoploss is at ₹618.28 and 2nd (wider) stoploss is at ₹565.09.
MARKSANS PHARMA Share Price Target 2040
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 9% | ₹1,022.90 | ₹951.30 |
| 2 | 17% | ₹2,757.18 | ₹869.47 |
| 3 | 27% | ₹8,691.91 | - |
* Targets are projected using historical CAGR and market assumptions.
Marksans Pharma Share Price Target 2040 is ₹1,022.90 (9% CAGR), 2nd target is ₹2,757.18 (17% CAGR), and 3rd target is ₹8,691.91 (27% CAGR). For risk management, the 1st stoploss is at ₹951.30 and 2nd (wider) stoploss is at ₹869.47.
MARKSANS PHARMA Share Price Target 2045
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 9% | ₹1,573.86 | ₹1,463.69 |
| 2 | 17% | ₹6,044.98 | ₹1,337.78 |
| 3 | 27% | ₹28,716.67 | - |
* Targets are projected using historical CAGR and market assumptions.
Marksans Pharma Share Price Target 2045 is ₹1,573.86 (9% CAGR), 2nd target is ₹6,044.98 (17% CAGR), and 3rd target is ₹28,716.67 (27% CAGR). For risk management, the 1st stoploss is at ₹1,463.69 and 2nd (wider) stoploss is at ₹1,337.78.
MARKSANS PHARMA Share Price Target 2050
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 9% | ₹2,421.58 | ₹2,252.07 |
| 2 | 17% | ₹13,253.30 | ₹2,058.35 |
| 3 | 27% | ₹94,875.18 | - |
* Targets are projected using historical CAGR and market assumptions.
Marksans Pharma Share Price Target 2050 is ₹2,421.58 (9% CAGR), 2nd target is ₹13,253.30 (17% CAGR), and 3rd target is ₹94,875.18 (27% CAGR). For risk management, the 1st stoploss is at ₹2,252.07 and 2nd (wider) stoploss is at ₹2,058.35.
Marksans Pharma Share Price Prediction 2026 - 2050
Marksans Pharma Share Price forecast from 2026 to 2050. Here you will find the target and stoploss levels based on historical performance, CAGR projections, and market analysis. You can also use CAGR calculator to find out target as per your desired CAGR returns.
| Year | T1 (9%) | T2 (17%) | T3 (27%) | SL 1 (7%) | SL 2 (15%) | SL 3 (22%) |
|---|---|---|---|---|---|---|
| 2026 | ₹333.65 | ₹367.32 | ₹373.44 | ₹290.80 | ₹260.19 | - |
| 2027 | ₹333.65 | ₹358.14 | ₹388.75 | ₹310.29 | ₹283.60 | - |
| 2028 | ₹363.68 | ₹419.02 | ₹493.71 | ₹338.22 | ₹309.13 | - |
| 2029 | ₹396.41 | ₹490.25 | ₹627.01 | ₹368.66 | ₹336.95 | - |
| 2030 | ₹432.09 | ₹573.60 | ₹796.30 | ₹401.84 | ₹367.27 | - |
| 2035 | ₹664.82 | ₹1,257.58 | ₹2,630.85 | ₹618.28 | ₹565.09 | - |
| 2040 | ₹1,022.90 | ₹2,757.18 | ₹8,691.91 | ₹951.30 | ₹869.47 | - |
| 2045 | ₹1,573.86 | ₹6,044.98 | ₹28,716.67 | ₹1,463.69 | ₹1,337.78 | - |
| 2050 | ₹2,421.58 | ₹13,253.30 | ₹94,875.18 | ₹2,252.07 | ₹2,058.35 | - |
OTHER STOCKS
Aarti Industries Share Price Target Alok Industries Share Price Target Amara Raja Batteries Share Price Target Amber Enterprises Share Price Target Ambuja Cement Share Price Target Anantraj Share Price Target Angel One Share Price Target Apollo Hospitals Share Price TargetMarksans Pharma Share News Today | Latest News | Price Target Analysis
Marksans Pharma Share Price Target 2026 to 2050
About Marksans Pharma
Marksans Pharma is a pharmaceutical company that makes generic medicines. Their products cover areas like pain relief, cardiovascular, and anti-diabetic treatments.
They export medicines to several countries, supporting global healthcare.
In simple words, Marksans Pharma is the company that provides affordable medicines for everyday health needs.
Top 5 Key Takeaways: Marksans Pharma (MARKSANS ) Share Price Performance
- Current Valuation: Trading at ₹306.10 (Healthcare sector) as of 2026-11-17. Today's movement is -3.10 (-1.00%).
- Short-Term Returns: 1-Day: -1.00% | 1-Week: -0.86% | 1-Month: -1.58%.
- Long-Term Returns: 6-Month: +47.55% | 1-Year: +56.89% | 3-Year: +118.25% | 5-Year: +417.94%.
- Best vs. Worst Year: Peak return in 2020 (+253.64%); lowest return in 2025 (-40.82%).
- Historical Consistency: Average annual return of +69.93% over 8 years, yielding positive returns in 5/8 years.
Top Technical Indicators Used by Traders and Investors to Calculate Share Price Target of Marksans Pharma
1. Volume Weighted Average Price (VWAP)
Volume Weighted Average Price (VWAP) calculates the average traded price weighted by trading volume over a specified session. It is widely used by intraday traders to assess whether prices are trading above or below the session's volume-weighted average. VWAP can also help identify potential dynamic support and resistance levels and evaluate trade execution.
2. Stochastic Oscillator
The Stochastic Oscillator compares a security's closing price with its recent high-low range. It ranges from 0 to 100, with readings above 80 often considered overbought and below 20 considered oversold. Traders use %K and %D line crossovers, momentum changes, and divergences to identify potential trading opportunities.
3. On-Balance Volume (OBV)
On-Balance Volume (OBV) is a volume-based indicator that adds volume on days when prices close higher and subtracts volume when prices close lower. It helps traders examine whether buying or selling volume is supporting a price trend. Divergences between OBV and price movements may signal a potential change in market momentum.
4. Fibonacci Retracement
Fibonacci Retracement is a charting tool used to identify potential support and resistance levels during a price correction. Common retracement levels include 23.6%, 38.2%, 50%, 61.8%, and 78.6%. Traders plot these levels between significant price swings to assess possible pullback zones and potential areas where a trend could resume.
5. Supertrend
Supertrend is a trend-following indicator calculated using the Average True Range (ATR) and a selected multiplier. It displays a trend line that changes position according to price movements and market volatility. Traders often use a green line to identify bullish conditions and a red line to identify bearish conditions, depending on the chart settings.
Trusted by Traders
Best Broker for Beginners in India
Simple interfaces, free demos, and great support for new Nifty traders.
IIFL
Established brand offering detailed research reports and comprehensive option charting.
Axis Direct
Premium trading experience supported by research and reliable historical data.
Aditya Birla Money
Backed by a large business group, offering reliable research and a stable trading platform.
Dhan
Modern platform with advanced option charts, enabling free backtesting of Nifty strategies.
Frequently asked questions on Marksans Pharma Share Price
Yes Marksans Pharma is a public sector company,
Marksans Pharma is now a 100% Debt free company.
Marksans Pharma is a good stock to invest for long term, however you may well keep this in mind that psu stocks some times underperform overall market for several years. if you have patience to hold then only you can invest for long term or invest with a time based or price based stop loss
In covid crash the Marksans Pharma share price fell as low as Rs.20 from it all time high
Yes, Marksans Pharma stock is highly liquid, which allows to enter and exit quickly.
No. A investor or trader should never invest all his capital in a single share, however he must create a portfolio of stocks
Data sourced from NSE and BSE public records, calculated using adjusted closing prices.